How does Breo Ellipta compare to Symbicort and other alternative inhalers for COPD?

Breo Ellipta, like Symbicort, is a combination inhaler used to manage COPD symptoms, but it differs in active ingredients, dosing frequency, and inhaler design, which may affect individual preference and response.

Overview

People with COPD often compare inhalers to find the best fit for their lifestyle and symptom control. Breo Ellipta and Symbicort are frequently discussed due to their popularity and effectiveness. This comparison can help guide a discussion with your healthcare provider about what’s right for you.

• Breo Ellipta and Symbicort both combine a corticosteroid and a long-acting bronchodilator.
• They differ in how often they’re taken and their exact ingredients.
• Your choice may depend on symptoms, side effects, and ease of use.

This helps explain why understanding each option is key before starting treatment.

Detailed Information

How it works

Breo Ellipta contains fluticasone furoate (a corticosteroid) and vilanterol (a long-acting beta agonist). This combination may reduce inflammation and relax airway muscles to improve breathing, usually with once-daily use.

Symbicort includes budesonide and formoterol, offering a similar anti-inflammatory and bronchodilator effect but is typically taken twice daily. The difference in medication timing and active ingredients may influence how each works for certain patients.

Clinical applications

Breo Ellipta is approved for daily maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma in certain adults, according to official Israeli registration information. Symbicort is also used for maintenance of COPD and asthma but offers more flexible dosing in some cases.

Both should not be used for sudden breathing problems and require consistent use for best results.

Safety and Effectiveness

Safety profile

According to Drugs.com, common side effects of Breo Ellipta may include throat irritation, headache, or fungal infections in the mouth. Rare risks include increased heart rate or immune suppression with long-term use. Similar side effects are reported for other combination inhalers like Symbicort.

Patients should rinse their mouth after inhalation to reduce risk of oral thrush and report any worsening of symptoms to their provider.

FDA approval and indications

Breo Ellipta is FDA-approved for asthma and COPD maintenance in adults, not for acute episodes. It’s intended for regular daily use to manage chronic respiratory symptoms and help reduce flare-ups.

For any inhaler, appropriate use and follow-up with a healthcare provider are necessary to ensure safety and effectiveness.

Access and Availability

How to obtain safely

Breo Ellipta is a prescription medication available through licensed pharmacies like IsraelPharm. It’s important to consult your doctor to confirm if Breo is right for your COPD treatment plan and to receive proper instructions on its use.

Never start or switch inhalers without provider supervision.

Key Takeaways

• Breo Ellipta and Symbicort are both combination inhalers for COPD but differ in active ingredients and how frequently they’re used.
• Breo is typically taken once daily, using a dry powder inhaler with fluticasone furoate and vilanterol.
• Side effects can include oral thrush, cough, or dizziness and vary per user.
• Your choice of inhaler should be made with a physician, based on your condition and symptom control needs.
• Prescription access through verified sources like IsraelPharm helps ensure safe, legal use.

FAQ

Can I use Breo Ellipta if I’ve already tried Symbicort?

Yes, some patients switch to Breo if Symbicort causes side effects or does not fully control symptoms. Always discuss changes with your doctor first.

Is Breo Ellipta easier to use than other inhalers?

Users often find Breo’s once-daily dosing and dry powder inhaler convenient. However, technique varies between inhalers, so ease of use depends on individual ability and preference.

Is Breo Ellipta safe for long-term use?

Breo is approved for long-term COPD maintenance, but chronic use may come with risks like decreased immune response or oral infections. Regular monitoring by a healthcare provider is recommended.

Is Breo covered by insurance or expensive to buy?

Cost depends on location and insurance. Options from global suppliers may offer savings, but should require a valid prescription.

What conditions does Breo actually treat?

Breo Ellipta is approved for the maintenance treatment of COPD and asthma in adults. It is not meant for quick relief during asthma attacks or sudden shortness of breath.